Jae Sevelius, PhD (Emeritus)

Headshot of Jae Sevelius
User Profile Photo

Jae Sevelius, PhD (Emeritus)

User Profile Name
Director, Center for AIDS Prevention Studies (CAPS)
Professor, School of Medicine
User Profile Title
User Profile Email


Jae Sevelius, PhD, is a licensed clinical psychologist whose research focuses on the investigation of risk and protective factors in transgender and gender diverse communities and relationships between intersectional stigma, gender affirmation, and health-related behaviors and outcomes. Most recently, Dr. Sevelius’ research has focused on developing and testing peer-led interventions to promote sexual health and resilience among transgender people by addressing intersectional stigma among transgender women of color and those affected by HIV.

Dr. Sevelius is Director of the Center for AIDS Prevention Studies (CAPS), Co-Director of the CAPS Developmental Core, and PI and co-founder of the Center of Excellence for Transgender Health.

User Profile Bio

Displaying 1 - 25 of 86

  1. Jain JP, Hill M, Gamarel KE, Santos GM, Johnson MO, Neilands TB, Dilworth SE, Reback CJ, Sevelius J. Socio-ecological Barriers to Viral Suppression Among Transgender Women Living with HIV in San Francisco and Los Angeles, California. AIDS Behav. 2023 Jan 22.
  2. Hill M, Sevelius J, Sherman ADF, Balthazar M, Klepper M, Radix A, Rebchook G, Hansen N. The Helping Networks of Transgender Women Living with HIV. J Community Health. 2023 Jan 20.
  3. Sevelius JM, Castro DA, Warri V, Moreta Avila L, Chakravarty D, Zamudio-Haas S, Kramer K, Monico Klein K, Zack B. Adapting and Implementing an Evidence-Based Reentry Intervention for Incarcerated Transgender Women: Lessons Learned. J Correct Health Care. 2023 Jan 02.
  4. Stangl, A. L., Atkins, K., Leddy, A. M., Sievwright, K. M., Sevelius, J. M., Lippman, S. A., Veras, M. A., Zamudio-Haas, S., Smith, M. K., Pachankis, J. E., Logie, C. H., Rao, D., Weiser, S., & Nyblade, L. . What do we know about interventions to reduce intersectional stigma and discrimination in the context of HIV? A systematic review. Stigma and Health. 2022.
  5. Stauffer CS, Brown MR, Adams D, Cassity M, Sevelius J. MDMA-assisted psychotherapy; Inclusion of transgender and gender diverse people in the frontiers of PTSD treatment trials. Front Psychiatry. 2022; 13:932605.
  6. Vance SR, Boyer CB, Glidden DV, Sevelius J. Comparing Substance Use and School-Based Stressors Among Black and Latinx Transgender Youth and Peers With Shared Minoritized Identities. J Adolesc Health. 2022 Oct 09.
  7. Bindman J, Ngo A, Zamudio-Haas S, Sevelius J. Health Care Experiences of Patients with Nonbinary Gender Identities. Transgend Health. 2022 Oct; 7(5):423-429.
  8. Rebchook GM, Chakravarty D, Xavier JM, Keatley JG, Maiorana A, Sevelius J, Shade SB, SPNS Transgender Women of Color Study Group. An evaluation of nine culturally tailored interventions designed to enhance engagement in HIV care among transgender women of colour in the United States. J Int AIDS Soc. 2022 10; 25 Suppl 5:e25991.
  9. Gamarel KE, Rebchook G, McCree BM, Jadwin-Cakmak L, Connolly M, Reyes LA, Sevelius JM. The ethical imperative to reduce HIV stigma through community-engaged, status-neutral interventions designed with and for transgender women of colour in the United States. J Int AIDS Soc. 2022 07; 25 Suppl 1:e25907.
  10. Sievwright KM, Stangl AL, Nyblade L, Lippman SA, Logie CH, Veras MASM, Zamudio-Haas S, Poteat T, Rao D, Pachankis JE, Kumi Smith M, Weiser SD, Brooks RA, Sevelius JM. An Expanded Definition of Intersectional Stigma for Public Health Research and Praxis. Am J Public Health. 2022 06; 112(S4):S356-S361.
  11. Hope, D. A., Holt, N. R., Woodruff, N., Mocarski, R., Meyer, H. M., Puckett, J. A., Eyer, J., Craig, S., Feldman, J., Irwin, J., Pachankis, J., Rawson, K. J., Sevelius, J., & Butler, S. . Bridging the gap between practice guidelines and the therapy room: Community-derived practice adaptations for psychological services with transgender and gender diverse adults in the central United States. Professional Psychology: Research and Practice. Advance online publication. 2022.
  12. Sevelius JM, Dilworth SE, Reback CJ, Chakravarty D, Castro D, Johnson MO, McCree B, Jackson A, Mata RP, Neilands TB. Randomized Controlled Trial of Healthy Divas: A Gender-Affirming, Peer-Delivered Intervention to Improve HIV Care Engagement Among Transgender Women Living With HIV. J Acquir Immune Defic Syndr. 2022 08 15; 90(5):508-516.
  13. Lippman SA, Sevelius JM, Saggese GSR, Gilmore H, Bassichetto KC, de Barros DD, de Oliveira RB, Maschião LF, Chen D, de Sousa Mascena Veras MA. Peer Navigation to Support Transgender Women's Engagement in HIV Care: Findings from the Trans Amigas Pilot Trial in São Paulo, Brazil. AIDS Behav. 2022 Aug; 26(8):2588-2599.
  14. Suen LW, Lunn MR, Sevelius JM, Flentje A, Capriotti MR, Lubensky ME, Hunt C, Weber S, Bahati M, Rescate A, Dastur Z, Obedin-Maliver J. Do Ask, Tell, and Show: Contextual Factors Affecting Sexual Orientation and Gender Identity Disclosure for Sexual and Gender Minority People. LGBT Health. 2022 Feb-Mar; 9(2):73-80.
  15. Bass SB, Kelly PJ, Brajuha J, Gutierrez-Mock L, Koester K, D'Avanzo P, Sevelius J. Exploring barriers and facilitators to PrEP use among transgender women in two urban areas: implications for messaging and communication. BMC Public Health. 2022 01 06; 22(1):17.
  16. Sevelius JM, Glidden DV, Deutsch M, Welborn L, Contreras A, Salinas A, Venegas L, Grant RM. Uptake, Retention, and Adherence to Pre-exposure Prophylaxis (PrEP) in TRIUMPH: A Peer-Led PrEP Demonstration Project for Transgender Communities in Oakland and Sacramento, California. J Acquir Immune Defic Syndr. 2021 12 15; 88(S1):S27-S38.
  17. Sevelius JM, Neilands TB, Reback CJ, Castro D, Dilworth SE, Kaplan RL, Johnson MO. An Intervention by and for Transgender Women Living With HIV: Study Protocol for a Two-Arm Randomized Controlled Trial Testing the Efficacy of "Healthy Divas" to Improve HIV Care Outcomes. Front Reprod Health. 2021; 3:665723.
  18. Downing J, Yee K, Sevelius JM. PrEP Use and Adherence Among Transgender Patients. AIDS Behav. 2022 Apr; 26(4):1251-1259.
  19. Johnson MO, Gandhi M, Fuchs JD, Sterling L, Sauceda JA, Saag MS, Riley ED, Sevelius JM. The impact of COVID-19 on mentoring early-career investigators: "Everything can wait. Listen more than usual and share your own struggles". Medicine (Baltimore). 2021 Oct 08; 100(40):e27423.
  20. Grant RM, Pellegrini M, Defechereux PA, Anderson PL, Yu M, Glidden DV, O'Neal J, Yager J, Bhasin S, Sevelius J, Deutsch MB. Sex Hormone Therapy and Tenofovir Diphosphate Concentration in Dried Blood Spots: Primary Results of the Interactions Between Antiretrovirals And Transgender Hormones Study. Clin Infect Dis. 2021 Oct 05; 73(7):e2117-e2123.
  21. Maiorana A, Sevelius J, Keatley J, Rebchook G. "She is Like a Sister to Me." Gender-Affirming Services and Relationships are Key to the Implementation of HIV Care Engagement Interventions with Transgender Women of Color. AIDS Behav. 2021 Jul; 25(Suppl 1):72-83.
  22. Sevelius J, Chakravarty D, Neilands TB, Keatley J, Shade SB, Johnson MO, Rebchook G, HRSA SPNS Transgender Women of Color Study Group . Evidence for the Model of Gender Affirmation: The Role of Gender Affirmation and Healthcare Empowerment in Viral Suppression Among Transgender Women of Color Living with HIV. AIDS Behav. 2021 Jul; 25(Suppl 1):64-71.
  23. Walters SM, Platt J, Anakaraonye A, Golub SA, Cunningham CO, Norton BL, Sevelius JM, Blackstock OJ. Considerations for the Design of Pre-exposure Prophylaxis (PrEP) Interventions for Women: Lessons Learned from the Implementation of a Novel PrEP Intervention. AIDS Behav. 2021 Dec; 25(12):3987-3999.
  24. Sevelius JM, Xavier J, Chakravarty D, Keatley J, Shade S, Rebchook G, SPNS Transgender Women of Color Study Group . Correlates of Engagement in HIV Care Among Transgender Women of Color in the United States of America. AIDS Behav. 2021 Jul; 25(Suppl 1):3-12.
  25. Sevelius J, Jackson A, Harzke AJ. Call for Special Issue Papers: Transgender Health and Corrections. J Correct Health Care. 2021 Jun; 27(2):71-72.